14C-labeled YM178
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Metabolic Processes
Conditions
Metabolic Processes
Trial Timeline
Jan 1, 2003 → Feb 1, 2003
NCT ID
NCT01651312About 14C-labeled YM178
14C-labeled YM178 is a phase 1 stage product being developed by Astellas Pharma for Metabolic Processes. The current trial status is completed. This product is registered under clinical trial identifier NCT01651312. Target conditions include Metabolic Processes.
What happened to similar drugs?
19 of 20 similar drugs in Metabolic Processes were approved
Approved (19) Terminated (4) Active (1)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01651312 | Phase 1 | Completed |
Competing Products
20 competing products in Metabolic Processes